Mochida Pharmaceutical stock heads toward October 30 earnings date

Published on 10/08/2026 at 09:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mochida Pharmaceutical stock reported JPY 31.719 billion in Q1 2026 revenue, while net income reached JPY 3.178 billion. The October 30 earnings date is next.

Mochida, JP3922800002, Illustration mit AI erstellt.

Mochida Pharmaceutical (ISIN JP3922800002) will publish its next earnings report on October 30, 2026, giving investors a defined checkpoint after a sharp improvement in its latest quarter. TradingView lists October 30, 2026 as the next earnings date for Mochida Pharmaceutical.

October 30 is the next checkpoint

The latest reported quarter ended June 30, 2026. According to Investing.com, revenue reached JPY 31.719 billion, compared with JPY 29.464 billion in the previous quarter, an increase of 7.65 percent.

Net income rose to JPY 3.178 billion from JPY 1.561 billion in the previous quarter, an increase of 103.59 percent. Diluted earnings per share reached JPY 89.75 in Q1 2026, making the October report important for judging whether the earnings improvement continues.

Profit growth meets a softer share price

Mochida Pharmaceutical stock was last at JPY 3,080 on the Tokyo Stock Exchange at 3:30 p.m. JST on October 8, 2026, down JPY 30, or 0.96 percent, from the prior close. The price stood 22.32 percent below its 52-week high of JPY 3,965 and above the 52-week low of JPY 2,929.

Market capitalization was JPY 108.9 billion on October 8, 2026, while trading volume reached 56,300 shares. The combination of higher quarterly profit and a share price below the yearly high leaves the October report as the next measurable test for the stock.

Tokyo listing defines the investment profile

6ix identifies Mochida Pharmaceutical as a Tokyo Stock Exchange listing under ticker 4534 in the pharmaceuticals industry. The company develops, manufactures and sells pharmaceuticals and healthcare products, with its business organized around pharmaceutical and healthcare product activities.

Yuhodb identifies Mochida Pharmaceutical as a Tokyo Stock Exchange Prime Market company with ISIN JP3922800002 and TOPIX Small 2 membership. Its fiscal year ended March 31, 2026, with annual revenue of JPY 117.0 billion and net income of JPY 7.9 billion.

Stock trades below its yearly high

Mochida Pharmaceutical stock was last at JPY 3,080 on the Tokyo Stock Exchange at 3:30 p.m. JST on October 8, 2026, while its market capitalization was JPY 108.9 billion. The October 30 earnings date now provides the next concrete event for assessing the durability of the Q1 profit increase.